Anika Therapeutics Inc. (ANIK) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-10
5:49 pm
Purchase
2020-12-3113GAnika Therapeutics, Inc.
ANIK
Kayne Anderson Rudnick Investment Management, LLC1,546,263
10.880%
48,154increase
(+3.21%)
Filing
History
2021-02-10
10:30 am
Purchase
2020-12-3113GAnika Therapeutics, Inc.
ANIK
The Vanguard Group934,282
6.570%
18,686increase
(+2.04%)
Filing
History
2021-02-10
09:48 am
Purchase
2020-03-1713GAnika Therapeutics, Inc.
ANIK
Renaissance Technologies LLC809,117
5.690%
809,117increase
(New Position)
Filing
History
2021-02-05
11:08 am
Sale
2020-12-3113GAnika Therapeutics, Inc.
ANIK
STATE STREET CORP
STT
820,746
5.770%
-39,761decrease
(-4.62%)
Filing
History
2021-01-25
4:56 pm
Purchase
2020-12-3113GAnika Therapeutics, Inc.
ANIK
BlackRock Inc.
BLK
2,250,290
15.800%
123,041increase
(+5.78%)
Filing
History
Goto Prev, 0, 1, 2